Based on the FDA Adverse Events Reporting System (FAERS), a public database that contains nearly 17 million (adverse event) AE reports, EGFR TKIs have been associated with HF and cardiac arrhythmias such as atrial fibrillation and QT prolongation (117). This evidence concerns the gene EGFR and cardiac rhythm disease.